85 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
not relied upon any Underwriter or legal counsel for any Underwriter for any legal, tax or accounting advice in connection with the offering and sale … and timely filed all federal, state, foreign and other tax returns or other statements that are or were required to be filed by it, if any, and has paid
424B5
6cp31tqm
13 Mar 24
Prospectus supplement for primary offering
4:04pm
424B5
kwabj74 ca
11 Mar 24
Prospectus supplement for primary offering
4:06pm
8-K
EX-10.1
ipd5ig h8mdhi1cwnxk
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
cf8qh4dt2t6c
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-99.1
jrpuh0
8 Aug 23
Cognition Therapeutics Reports Second Quarter 2023 Financial Results and Business Update
7:05am
8-K
EX-99.1
c0dq dt47hssqcs0pp
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
EX-10.1
lpodlu
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-10.1
xvk 8dgh2yl11
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
jk4drjijvev3jfdsec
23 Dec 22
Shelf registration
4:16pm
S-3
up6bylyo
23 Dec 22
Shelf registration
4:16pm